The Society for Immunotherapy of Cancer (SITC) announced that Gordon Freeman, PhD, of Dana-Farber Cancer Institute is the co-recipient…
eabramovichJune 29, 2020
A new study reveals a possible biological reason that Alzheimer’s Disease (AD) progresses at different rates in…
eabramovichJune 29, 2020
In its Brain Targeting Program, a Wyss team led by Founding Director Donald Ingber, M.D., Ph.D.…
eabramovichJune 29, 2020
Yumanity Therapeutics and Merck signed a strategic research and license deal for two Yumanity programs. The two preclinical programs…
eabramovichJune 26, 2020
Using computational models of protein interactions, researchers at the MIT Media Lab and Center for…
eabramovichJune 26, 2020
Thirty-one of the nation’s rising stars in science were announced today as the 2020 Finalists…
eabramovichJune 26, 2020
Stefan G. Tullius, MD, PhD, has been awarded a National Institutes of Health (NIH) grant…
eabramovichJune 26, 2020
The authors demonstrate that agents that raise cGMP and activate the cGMP-dependent protein kinase (PKG),…
eabramovichJune 26, 2020
Tuberous sclerosis complex (TSC) is a neurological disorder causing non-cancerous tumors, called cortical tubers, to…
eabramovichJune 25, 2020
